Search Results - "Brennan, A.L"

182 Impact of ivacaftor on glycaemic health in patients carrying the G551D mutation by Barry, P.J, Banerjee, A, Horsley, A, Brennan, A.L

“…Objectives Ivacaftor has led to significant benefits for patients with CF carrying the G551D mutation. The multisystem effects of CFTR modulation is…”
Get full text

WS09.9 Learning from patient deaths in CF: An audit of team debrief sessions at a UK adult CF centre by Reid, N, Oxley, H, Dowdall, F, Brennan, A.L

“…Objectives End of life care in CF has become increasingly medicalised. Aggressive measures introduced to treat end stage respiratory disease as a bridge to…”
Get full text

165 “Real world” introduction of tobramycin inhalation powder TIP™ in adults with cystic fibrosis by Langman, H.B, Brennan, A.L, Bright-Thomas, R.J, Jones, A.M, Riley, D.W, Johnson, S.C

“…Objectives To evaluate the introduction of TIP in adult patients attending Manchester Adult Cystic Fibrosis Centre. Methods In December 2012 TIP was introduced…”
Get full text

WS08.3 “Real world” experience of introduction of Colobreathe™ (Colo) in adults with cystic fibrosis by Langman, H.B, Brennan, A.L, Bright-Thomas, R.J, Jones, A.M, Riley, D.W, Johnson, S.C

“…Objectives To evaluate the introduction of Colo in adult patients attending Manchester Adult Cystic Fibrosis Centre. Methods Colo was introduced in August 2013…”
Get full text

Patient segregation and aggressive antibiotic eradication therapy can control methicillin-resistant Staphylococcus aureus at large cystic fibrosis centres by Doe, S.J, McSorley, A, Isalska, B, Kearns, A.M, Bright-Thomas, R, Brennan, A.L, Webb, A.K, Jones, A.M

“…Abstract Background The prevalence of MRSA in patients with CF has risen in recent years. We adhere to a policy of segregation and barrier nursing to manage…”
Get full text

PSU10 Costs of Cardiovascular Readmissions Following Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease: Data From a Large Multi-Centre Australian Registry by Ariyaratne, T.V, Ademi, Z, Duffy, S.J, Andrianopoulos, N, Billah, B, Brennan, A.L, Clark, D.J, New, G, Black, A, Ajani, A.E, Yan, B.P, Reid, C.M

Get full text

134 Validity of a symptom questionnaire for the diagnosis of viral respiratory infection in adults with CF by Flight, W.G, Horsley, A, Brennan, A.L, Mutton, K.J, Webb, K, Bright-Thomas, R.J, Jones, A

Get full text

Use of continual glucose monitoring to assess real life glycaemia in adults with CF by Helm, J.M, Rowe, R, Brennan, A.L, Jones, A.M, Webb, A.K

Get full text

Adoptive transfer of gene-modified T-cells engineered to express high-affinity tcr's for cancer-testis antigens NY-ESO-1 or lage-1, in multiple myeloma (MM) patients post autologous hematopoietic stem cell transplant (ASCT) by Levine, B.L, Rapoport, A.P, Stadtmauer, E.A, Vogl, D.T, Weiss, B, Binder-Scholl, G.K, Smethurst, D.P, Brewer, J.E, Bennett, A.D, Gerry, A.B, Pumphrey, N.J, Tayton-Martin, H.K, Ribiero, L, Veloso, E.A, Finklestein, J, Kulikovskaya, I, Gupta, M, Suppa, E, Mikheeva, T, Zheng, Z, Brennan, A.L, Bersenev, A, Tripic, T, Cribioli, E, Cotte, J, Badros, A.Z, Yanovich, S, Akpek, G, McConville, H, Kerr, N, Philip, S, Betts, K, Westphal, S, Kalos, M, Jacobsen, B.K, June, C.H

Get full text

Do prophylactic antibiotics reduce isolation of Staphylococcus aureus in adult CF patients? by Brennan, A.L, Aul, R, Dodd, M.E, Webb, A.K, Jones, A.M

Get full text

Hospital survival in patients with out of hospital cardiac arrest undergoing percutaneous coronary intervention by Lim, H.S, Farouque, O, Lim, C.C.S, Andrianopoulos, N, Brennan, A.L, Moore, M, New, G, Ajani, A.E, Duffy, S.J, Clark, D.J

Get full text

Process Development and Manufacturing: DEVELOPMENT AND FEASIBILITY OF RELEASE ASSAYS TO TEST FOR CD33-KNOCKOUT EFFICIENCY AND POTENCY OF GENE-MODIFIED CD34+ HSCS FOR LARGE-SCALE MANUFACTURED PRODUCTS by Petrella, J., Dai, A., Mackey, S., Ngo, S., Brennan, A.L., Correa, A., Colligon, T.A., Tran, K., Buchholz, K., Plesa, G., Siegel, D.

Get full text

872 - Process Development and Manufacturing: DEVELOPMENT AND FEASIBILITY OF RELEASE ASSAYS TO TEST FOR CD33-KNOCKOUT EFFICIENCY AND POTENCY OF GENE-MODIFIED CD34+ HSCS FOR LARGE-SCALE MANUFACTURED PRODUCTS by Petrella, J., Dai, A., Mackey, S., Ngo, S., Brennan, A.L., Correa, A., Colligon, T.A., Tran, K., Buchholz, K., Plesa, G., Siegel, D.

Get full text

HARNESSING POTENT NAÏVE LIKE T CELLS FOR PRECISION CAR T MANUFACTURING by Jain, A., Amses, K., Markovska, M., Haines, K.M., Gohil, M., Pequignot, E., Sporici, K., Uhera, Y., Trivedi, H., Brennan, A.L., Plesa, G., Young, R., June, C., Sherrill-Mix, S.A., Everett, J.K., Siegel, D., Bushman, F.D., Fraietta, J.A., Weber, E.W., Davis, M.M.

“…T cell fitness and differentiation status are critical factors that influence the manufacturing (MFG) of effective autologous cell therapy products, including…”
Get full text

ePS2.02 Assessing cardiovascular risk in an older cystic fibrosis patient cohort: implications of Cystic Fibrosis-Related Diabetes classification by Paterson, S.L., Bright-Thomas, R.J., Jones, A.M., Kelly, A.-M., Brennan, A.L.

Get full text

ePS2.01 Prevalence of hypertension in cystic fibrosis by Logue, C., Smith, C.M.T., Nath, N., Beynon, J., Tofeec, K., Brennan, A.L.

Get full text

Process Development and Manufacturing: MULTIPLE EFFICIENCIES GAINED BY IMPLEMENTING A SIGNIFICANTLY SHORTER MANUFACTURING SCHEDULE FOR PRODUCTION OF CAR T CELL PRODUCTS by Plesa, G., Brennan, A.L., Levine, J. Rojas, Hasenmayer, D., Buchholz, K., Migliaccio, T., Holland, D., Colligon, T.A., Mackey, S., Dai, A., Petrella, J., Ngo, S., Fesnak, A., Davis, M.M., Siegel, D.

Get full text

4 - Process Development and Manufacturing: MULTIPLE EFFICIENCIES GAINED BY IMPLEMENTING A SIGNIFICANTLY SHORTER MANUFACTURING SCHEDULE FOR PRODUCTION OF CAR T CELL PRODUCTS by Plesa, G., Brennan, A.L., Levine, J. Rojas, Hasenmayer, D., Buchholz, K., Migliaccio, T., Holland, D., Colligon, T.A., Mackey, S., Dai, A., Petrella, J., Ngo, S., Fesnak, A., Davis, M.M., Siegel, D.

Get full text

P141 Has the COVID-19 pandemic affected medication adherence to inhaled nebulised therapy for patients at a large adult cystic fibrosis centre? by Iqbal, N., Nadat, Z., Vessey, J.E., Martin, K.J., Brennan, A.L., Bright-Thomas, R.J., Green, H.D., Jones, A.M., Barry, P.J.

Get full text

Implementation of new cell washing technology in an academic cell therapy manufacturing laboratory by Hasenmayer, D., Lamontagne, A., Lewitt, L., Oner, S., Buchholz, K., Tran, K., Rojas Levine, J., Brennan, A.L., Fox, E., Ngo, S., McKenna, S., Plesa, G., Siegel, D.

Get full text